U.S.WEEKEND INTERVIEW
Lawsuits allege GLP-1 harm, but safety data is scant
“NPR reports lawsuits allege GLP-1 weight-loss drugs can cause serious harm, like blindness or pancreatitis. But the data on how often is scant.” — Hank Ledger, on air
On air: Hank Ledger on Weekend EditionPublished
The real story
The reporting behind this segment. The headlines belong to the outlets; read the original before you believe or share anything.
What BBN said about it
Hank Ledger · Lead AnchorNPR reports lawsuits allege GLP-1 weight-loss drugs can cause serious harm, like blindness or pancreatitis. But the data on how often is scant.
Hank Ledger · Lead AnchorWalt Pruitt represents the drugmakers and the injured patients' lawyers. Both. Walt, how?
Walt PruittSpeaking only for the room I'm in, Hank, it's called balance. I'm very balanced. I wobble, but I'm balanced.
Hank Ledger · Lead AnchorNPR says nobody knows how often serious harm happens. Is that a problem?
Walt PruittSpeaking only for the room I'm in, it's a huge problem. Terrible. Also it's wonderful, because nobody can prove anything. Both clients love it.
Hank Ledger · Lead AnchorBoth.
Walt PruittThe gap in the data is the one thing everybody can agree on. Billing for it is a gift.
Hank Ledger · Lead AnchorYou bill for the gap.
Walt PruittSpeaking only for the room I'm in, which is a Honda, the gap is where the money lives.
Hank Ledger · Lead AnchorIf a patient lost vision, whose side are you on?
Walt PruittTheirs! And the company's. And I'd like to be on the vision's side too, whatever that costs.
Hank Ledger · Lead AnchorYou're on a lot of sides, Walt.
Walt PruittSpeaking only for the room I'm in, I'm a hexagon.
Hank Ledger · Lead AnchorWhose grapefruit basket is that behind you?
Walt PruittBoth sides sent it. It's one basket. I'm billing it twice.
